Indanazoline hydrochloride

Indanazoline hydrochloride is an imidazoline-derivative, sympathomimetic nasal decongestant. Primarily formulated as a nasal spray, it treats acute, chronic, and allergic rhinitis by stimulating α-adrenergic receptors in the nasal mucosa. This triggers vasoconstriction, reducing blood flow and swelling to clear congested airways. It is grouped under the following drug class(es): Vasoconstrictors. Its therapeutic use is listed as decongestants. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include N-(2-Imidazoline-2-yl)-N-(4-indanyl)amin-monohydrochlorid, N-(2, 3-Dihydro-1H-inden-4-yl)-4 and 5-dihydro-1H-imidazol-2-amine–hydrogen chloride (1/1). Its PubChem CID is 162014.

CAS No 40507-80-0
Molecular Formula C12H16ClN3
Molecular Weight 237.73 g/mol
Synonyms N-(2,3-dihydro-1H-inden-4-yl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride

Frequently Asked Questions